BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3157247)

  • 21. Phorbol ester tumor promoter modulation of alloantigen-specific T lymphocyte responses.
    Andreotti PE
    J Immunol; 1982 Jul; 129(1):91-6. PubMed ID: 6177764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
    Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase C required for cytotoxic T lymphocyte triggering.
    Nishimura T; Burakoff SJ; Herrmann SH
    J Immunol; 1987 Nov; 139(9):2888-91. PubMed ID: 3499460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium ionophore plus phorbol ester can substitute for antigen in the induction of cytolytic T lymphocytes from specifically primed precursors.
    Truneh A; Albert F; Golstein P; Schmitt-Verhulst AM
    J Immunol; 1985 Oct; 135(4):2262-7. PubMed ID: 2411789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on T-lymphocyte activation. I. Is competence inductions in thymocytes by phorbol myristate acetate, an accessory cell-independent event?
    Diamantstein T; Klos M; Reimann J
    Immunology; 1981 May; 43(1):183-9. PubMed ID: 6972903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
    Susskind BM; Chandrasekaran J
    J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.
    Suzawa T; Hyodo S; Kishi T; Kashiwa H; Karakawa T; Kittaka E; Sakano T; Usui T
    Immunology; 1984 Nov; 53(3):499-505. PubMed ID: 6333386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate.
    Sagone AL; Husney R; Guter H; Clark L
    J Immunol; 1984 Sep; 133(3):1488-94. PubMed ID: 6747295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-independent activation of cytotoxic T cells by lymphokines.
    Williams LD; McMaster WR; Teh HS
    Immunology; 1988 May; 64(1):121-8. PubMed ID: 3133307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the Fas lytic pathway in cloned CTL.
    Glass A; Walsh CM; Lynch DH; Clark WR
    J Immunol; 1996 May; 156(10):3638-44. PubMed ID: 8621897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-independent activation of memory cytotoxic T cells by interleukin 2.
    Lefrancois L; Klein JR; Paetkau V; Bevan MJ
    J Immunol; 1984 Apr; 132(4):1845-50. PubMed ID: 6230394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phorbol-induced recruitment of lymphocytes for spontaneous cytolysis of natural killer-insensitive tumor targets.
    Nabi ZF; Zucker-Franklin D
    Cell Immunol; 1986 Jul; 100(2):485-500. PubMed ID: 3093088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of T cell activation requirements with the use of alloantigens or an anti-clonotypic monoclonal antibody.
    Hua C; Boyer C; Guimezanes A; Albert F; Schmitt-Verhulst AM
    J Immunol; 1986 Mar; 136(6):1927-36. PubMed ID: 2936814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tumour promoter phorbol myristate acetate on mouse lymphocytes: selective inhibition of B cell activation by mitogens and antigens.
    Hawrylowicz CM; Klaus GG
    Immunology; 1984 Feb; 51(2):327-32. PubMed ID: 6607211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of human T-lymphocyte colonies by phorbol myristate acetate.
    Suzawa T; Hyodo S; Kishi T; Kashiwa H; Kittaka E; Sakano T; Usui T
    Immunology; 1983 Dec; 50(4):575-80. PubMed ID: 6606613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of selective tumor cell binding by activated murine macrophages in response to phorbol myristate acetate.
    Somers SD; Adams DO
    J Immunol; 1986 Mar; 136(6):2323-32. PubMed ID: 3512713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of human T-lymphoid leukemia cells into cells that have a suppressor phenotype is induced by phorbol 12-myristate 13-acetate.
    Ryffel B; Henning CB; Huberman E
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7336-40. PubMed ID: 6218499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
    Thiele DL; Patel SS; Lipsky PE
    J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell lines and variant subclones with differing susceptibility to tumor promoters.
    Di Pauli R; Rassat J
    J Immunol; 1983 Jun; 130(6):2732-6. PubMed ID: 6602179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitogenic effects of phorbol myristate acetate (PMA) on amphibian cells.
    Hsu E; Leanderson T; Franklin RM
    Ann Inst Pasteur Immunol (1985); 1985; 136D(2):105-18. PubMed ID: 3909928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.